Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

COVID-19 Sample Collection Kits Market by Product Type (Swabs, Viral Transport Media, Blood Collection Kits, Others), by Application (Diagnosis, Research) and by Site of Sample Collection (Hospitals, Clinics, Home Test): Global Opportunity Analysis and Industry Forecast, 2023-2032

A13191

Pages: NA

Charts: NA

Tables: NA

COVID-19 Sample Collection Kits Market 2030

COVID-19 sample collection is the most important step in the diagnosis of COVID-19 disease in the laboratory. Improper and inaccurate specimen collection can lead to false or negative test results. The sample collection kit is a new innovation in the field of sample collection. The collection, classification, and storage of samples have become the basic elements of clinical trial implementation and management. In today's dynamic clinical environment, the characteristics and reliability of COVID-19 sample collection kits have a huge impact on the acceptance and effectiveness of clinical trials. Nasal swabs, throat swabs, and blood samples are taken for the detection of COVID-19 and research on COVID-19.

COVID-19 Impact Analysis             

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID-19 is expected to have a significant impact on the COVID-19 sample collection kits market.

Top Impacting Factors

  • Sudden rise in cases of COVID-19 cases, increase in demand for accurate detection of COVID-19, surge in usage of early diagnosis procedures, increase in peoples suffering from weak immune system, and rise in number of hospital acquired infections are the major factors that drive the growth of the COVID-19 sample collection kits market.
  • In addition, surge in adoption of highly advance diagnostic tests, launch of novel technology in market such as 3D printed nasal swabs, rise in R&D activities to improve efficiency & accuracy of COVID-19 diagnosis, increase in government support to promote development in sample collection kits, and ongoing advancement by key market players are expected to fuel the growth of the COVID-19 sample collection kits market.
  • However, lack of accuracy in COVID-19 diagnosis hinder the growth of the COVID-19 sample collection kits market.
  • Contrarily, government initiatives to spread awareness regarding COVID-19 are expected to offer lucrative opportunities for the expansion of the market.

Market Trends

New Product Launches to Flourish the Market

In 2021, Door Dash announced launch of on demand delivery of COVID-19 PCR test collection kit through partnership with Vault Health and Everlywell. This kit help people for diagnosis of COVID-19 from home.

In 2021, Tempus launched COVID-19 home collection sample kit. This sample kit are used in self collection of specimen at home for detection of COVID-19

In 2021, Tempus announced launch of the research use only (RUO) amplicon based next generation sequencing kit for the detection of mutations from SARS-CoV2 virus.

In 2021, EmpowerX launched COVID-19 home detection sample kit on amazon. This product can be delivered at door step for diagnosis of COVID-19.

Key Benefits of the Report

  • This study presents the analytical depiction of Covid-19 sample collection kits market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the COVID-19 sample collection kits market share.
  • The current market is quantitatively analyzed to highlight the COVID-19 sample collection kits market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Covid-19 Sample Collection Kits Market Report        

  • Which are the leading players active in the Covid-19 sample collection kits market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "Covid-19 sample collection kits"?
  • What is "Covid-19 sample collection kits" market prediction in the future?
  • Who are the leading global players in the "Covid-19 sample collection kits" market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Covid-19 sample collection kits" market report?

 Key Market Segments

  • By Product Type
    • Swabs
    • Viral Transport Media
    • Blood Collection Kits
    • Others
  • By Application
    • Diagnosis
    • Research
  • By Site of Sample Collection
    • Hospitals
    • Clinics
    • Home Test
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Hardy Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics
  • Puritan Medical Products
  • Danaher Corporation
  • Quidel Corporation
  • Becton, Dickinson and Company
  • Trinity Biotech
  • Lucence Diagnostics Pte Ltd.
  • Vitagene Inc.
  • COPAN Diagnostics
  • Laboratory Corporation of America Holdings

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: COVID-19 SAMPLE COLLECTION KITS MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Swabs

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Viral Transport Media

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Blood Collection Kits

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Others

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: COVID-19 SAMPLE COLLECTION KITS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Diagnosis

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Research

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: COVID-19 SAMPLE COLLECTION KITS MARKET, BY SITE OF SAMPLE COLLECTION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Site Of Sample Collection

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Home Test

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: COVID-19 SAMPLE COLLECTION KITS MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product Type

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By Site Of Sample Collection

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Covid-19 Sample Collection Kits Market

        • 7.2.6.1. Market Size and Forecast, By Product Type
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.2.7. Canada Covid-19 Sample Collection Kits Market

        • 7.2.7.1. Market Size and Forecast, By Product Type
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.2.8. Mexico Covid-19 Sample Collection Kits Market

        • 7.2.8.1. Market Size and Forecast, By Product Type
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By Site Of Sample Collection

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product Type

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By Site Of Sample Collection

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Covid-19 Sample Collection Kits Market

        • 7.3.6.1. Market Size and Forecast, By Product Type
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.3.7. Germany Covid-19 Sample Collection Kits Market

        • 7.3.7.1. Market Size and Forecast, By Product Type
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.3.8. Italy Covid-19 Sample Collection Kits Market

        • 7.3.8.1. Market Size and Forecast, By Product Type
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.3.9. Spain Covid-19 Sample Collection Kits Market

        • 7.3.9.1. Market Size and Forecast, By Product Type
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.3.10. UK Covid-19 Sample Collection Kits Market

        • 7.3.10.1. Market Size and Forecast, By Product Type
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.3.11. Russia Covid-19 Sample Collection Kits Market

        • 7.3.11.1. Market Size and Forecast, By Product Type
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.3.12. Rest Of Europe Covid-19 Sample Collection Kits Market

        • 7.3.12.1. Market Size and Forecast, By Product Type
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By Site Of Sample Collection

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product Type

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By Site Of Sample Collection

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Covid-19 Sample Collection Kits Market

        • 7.4.6.1. Market Size and Forecast, By Product Type
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.4.7. Japan Covid-19 Sample Collection Kits Market

        • 7.4.7.1. Market Size and Forecast, By Product Type
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.4.8. India Covid-19 Sample Collection Kits Market

        • 7.4.8.1. Market Size and Forecast, By Product Type
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.4.9. South Korea Covid-19 Sample Collection Kits Market

        • 7.4.9.1. Market Size and Forecast, By Product Type
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.4.10. Australia Covid-19 Sample Collection Kits Market

        • 7.4.10.1. Market Size and Forecast, By Product Type
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.4.11. Thailand Covid-19 Sample Collection Kits Market

        • 7.4.11.1. Market Size and Forecast, By Product Type
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.4.12. Malaysia Covid-19 Sample Collection Kits Market

        • 7.4.12.1. Market Size and Forecast, By Product Type
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.4.13. Indonesia Covid-19 Sample Collection Kits Market

        • 7.4.13.1. Market Size and Forecast, By Product Type
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.4.14. Rest of Asia Pacific Covid-19 Sample Collection Kits Market

        • 7.4.14.1. Market Size and Forecast, By Product Type
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By Site Of Sample Collection

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product Type

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By Site Of Sample Collection

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Covid-19 Sample Collection Kits Market

        • 7.5.6.1. Market Size and Forecast, By Product Type
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.5.7. South Africa Covid-19 Sample Collection Kits Market

        • 7.5.7.1. Market Size and Forecast, By Product Type
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.5.8. Saudi Arabia Covid-19 Sample Collection Kits Market

        • 7.5.8.1. Market Size and Forecast, By Product Type
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.5.9. UAE Covid-19 Sample Collection Kits Market

        • 7.5.9.1. Market Size and Forecast, By Product Type
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.5.10. Argentina Covid-19 Sample Collection Kits Market

        • 7.5.10.1. Market Size and Forecast, By Product Type
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By Site Of Sample Collection

      • 7.5.11. Rest of LAMEA Covid-19 Sample Collection Kits Market

        • 7.5.11.1. Market Size and Forecast, By Product Type
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By Site Of Sample Collection

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Puritan Medical Products

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. COPAN Diagnostics

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Becton, Dickinson And Company

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Thermo Fisher Scientific, Inc.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Laboratory Corporation Of America Holdings

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Lucence Diagnostics Pte Ltd.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Hardy Diagnostics

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Trinity Biotech

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Quidel Corporation

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Quest Diagnostics

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Danaher Corporation

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

    • 9.12. Vitagene Inc.

      • 9.12.1. Company Overview

      • 9.12.2. Key Executives

      • 9.12.3. Company Snapshot

      • 9.12.4. Operating Business Segments

      • 9.12.5. Product Portfolio

      • 9.12.6. Business Performance

      • 9.12.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET FOR SWABS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET FOR VIRAL TRANSPORT MEDIA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET FOR BLOOD COLLECTION KITS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET FOR DIAGNOSIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET FOR RESEARCH, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET FOR CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET FOR HOME TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA COVID-19 SAMPLE COLLECTION KITS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 18. U.S. COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 19. U.S. COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. U.S. COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 21. CANADA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 22. CANADA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. CANADA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE COVID-19 SAMPLE COLLECTION KITS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 32. FRANCE COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 34. GERMANY COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 35. GERMANY COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 37. ITALY COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 38. ITALY COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. ITALY COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 40. SPAIN COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 41. SPAIN COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 43. UK COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 44. UK COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. UK COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 46. RUSSIA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 47. RUSSIA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 50. REST OF EUROPE COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC COVID-19 SAMPLE COLLECTION KITS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 56. CHINA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 57. CHINA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. CHINA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 59. JAPAN COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 60. JAPAN COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 62. INDIA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 63. INDIA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. INDIA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH KOREA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH KOREA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 68. AUSTRALIA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 69. AUSTRALIA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 71. THAILAND COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 72. THAILAND COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 74. MALAYSIA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 75. MALAYSIA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 77. INDONESIA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 78. INDONESIA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA COVID-19 SAMPLE COLLECTION KITS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 87. BRAZIL COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 88. BRAZIL COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH AFRICA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH AFRICA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 93. SAUDI ARABIA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 94. SAUDI ARABIA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 96. UAE COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 97. UAE COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 98. UAE COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 99. ARGENTINA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 100. ARGENTINA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 102. REST OF LAMEA COVID-19 SAMPLE COLLECTION KITS, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 103. REST OF LAMEA COVID-19 SAMPLE COLLECTION KITS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA COVID-19 SAMPLE COLLECTION KITS, BY SITE OF SAMPLE COLLECTION, 2025-2033 ($MILLION)
  • TABLE 105. PURITAN MEDICAL PRODUCTS: KEY EXECUTIVES
  • TABLE 106. PURITAN MEDICAL PRODUCTS: COMPANY SNAPSHOT
  • TABLE 107. PURITAN MEDICAL PRODUCTS: OPERATING SEGMENTS
  • TABLE 108. PURITAN MEDICAL PRODUCTS: PRODUCT PORTFOLIO
  • TABLE 109. PURITAN MEDICAL PRODUCTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. COPAN DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 111. COPAN DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 112. COPAN DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 113. COPAN DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 114. COPAN DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 116. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 117. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 118. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 119. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 121. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 122. THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
  • TABLE 123. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
  • TABLE 124. THERMO FISHER SCIENTIFIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY EXECUTIVES
  • TABLE 126. LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
  • TABLE 127. LABORATORY CORPORATION OF AMERICA HOLDINGS: OPERATING SEGMENTS
  • TABLE 128. LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCT PORTFOLIO
  • TABLE 129. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130. LUCENCE DIAGNOSTICS PTE LTD.: KEY EXECUTIVES
  • TABLE 131. LUCENCE DIAGNOSTICS PTE LTD.: COMPANY SNAPSHOT
  • TABLE 132. LUCENCE DIAGNOSTICS PTE LTD.: OPERATING SEGMENTS
  • TABLE 133. LUCENCE DIAGNOSTICS PTE LTD.: PRODUCT PORTFOLIO
  • TABLE 134. LUCENCE DIAGNOSTICS PTE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 135. HARDY DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 136. HARDY DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 137. HARDY DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 138. HARDY DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 139. HARDY DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 140. TRINITY BIOTECH: KEY EXECUTIVES
  • TABLE 141. TRINITY BIOTECH: COMPANY SNAPSHOT
  • TABLE 142. TRINITY BIOTECH: OPERATING SEGMENTS
  • TABLE 143. TRINITY BIOTECH: PRODUCT PORTFOLIO
  • TABLE 144. TRINITY BIOTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 145. QUIDEL CORPORATION: KEY EXECUTIVES
  • TABLE 146. QUIDEL CORPORATION: COMPANY SNAPSHOT
  • TABLE 147. QUIDEL CORPORATION: OPERATING SEGMENTS
  • TABLE 148. QUIDEL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 149. QUIDEL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 150. QUEST DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 151. QUEST DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 152. QUEST DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 153. QUEST DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 154. QUEST DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 155. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 156. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 157. DANAHER CORPORATION: OPERATING SEGMENTS
  • TABLE 158. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 159. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 160. VITAGENE INC.: KEY EXECUTIVES
  • TABLE 161. VITAGENE INC.: COMPANY SNAPSHOT
  • TABLE 162. VITAGENE INC.: OPERATING SEGMENTS
  • TABLE 163. VITAGENE INC.: PRODUCT PORTFOLIO
  • TABLE 164. VITAGENE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL COVID-19 SAMPLE COLLECTION KITS MARKET
  • FIGURE 3. SEGMENTATION COVID-19 SAMPLE COLLECTION KITS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN COVID-19 SAMPLE COLLECTION KITS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCOVID-19 SAMPLE COLLECTION KITS MARKET
  • FIGURE 11. COVID-19 SAMPLE COLLECTION KITS MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. COVID-19 SAMPLE COLLECTION KITS MARKET FOR SWABS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. COVID-19 SAMPLE COLLECTION KITS MARKET FOR VIRAL TRANSPORT MEDIA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. COVID-19 SAMPLE COLLECTION KITS MARKET FOR BLOOD COLLECTION KITS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. COVID-19 SAMPLE COLLECTION KITS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. COVID-19 SAMPLE COLLECTION KITS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 17. COVID-19 SAMPLE COLLECTION KITS MARKET FOR DIAGNOSIS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. COVID-19 SAMPLE COLLECTION KITS MARKET FOR RESEARCH, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. COVID-19 SAMPLE COLLECTION KITS MARKET SEGMENTATION, BY BY SITE OF SAMPLE COLLECTION
  • FIGURE 20. COVID-19 SAMPLE COLLECTION KITS MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. COVID-19 SAMPLE COLLECTION KITS MARKET FOR CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. COVID-19 SAMPLE COLLECTION KITS MARKET FOR HOME TEST, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 27. COMPETITIVE DASHBOARD
  • FIGURE 28. COMPETITIVE HEATMAP: COVID-19 SAMPLE COLLECTION KITS MARKET
  • FIGURE 29. TOP PLAYER POSITIONING, 2024
  • FIGURE 30. PURITAN MEDICAL PRODUCTS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. PURITAN MEDICAL PRODUCTS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. PURITAN MEDICAL PRODUCTS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. COPAN DIAGNOSTICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. COPAN DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. COPAN DIAGNOSTICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. BECTON, DICKINSON AND COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. LABORATORY CORPORATION OF AMERICA HOLDINGS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. LABORATORY CORPORATION OF AMERICA HOLDINGS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. LABORATORY CORPORATION OF AMERICA HOLDINGS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. LUCENCE DIAGNOSTICS PTE LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. LUCENCE DIAGNOSTICS PTE LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. LUCENCE DIAGNOSTICS PTE LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. HARDY DIAGNOSTICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. HARDY DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. HARDY DIAGNOSTICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. TRINITY BIOTECH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. TRINITY BIOTECH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. TRINITY BIOTECH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. QUIDEL CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. QUIDEL CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. QUIDEL CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. QUEST DIAGNOSTICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. QUEST DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. QUEST DIAGNOSTICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 60. DANAHER CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 61. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 62. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 63. VITAGENE INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 64. VITAGENE INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 65. VITAGENE INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
COVID-19 Sample Collection Kits Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved